Utano CRO

Monkeypox in Africa: Skin Symptoms Shouldn’t Be Overlooked 🦠 In Africa, the Mpox virus is spreading, yet many people are still mistaking its symptoms for other common illnesses. Many symptoms—especially distinctive skin rashes may be shrugged off or linked to other familiar ailments such as measles, delaying timely care. In our latest blog, we explore the transmission methods (animal and human contact), key symptoms to watch for, and the preventive actions to protect communities. Recognizing Mpox early on could be crucial in managing this virus. Catch up on the full blog to see why vigilance matters. 🔗 Read more here [https://lnkd.in/eR6E2TUG] and stay informed. #PublicHealth #MpoxAwareness #AfricaHealth #MonkeypoxOutbreak

🌍 Disease X: Africa’s Next Pandemic? Disease X isn’t an identified illness but a placeholder for a potential future pandemic that could shake the world. Africa’s history with zoonotic diseases and its close human-animal interactions have raised concerns that the continent could be where Disease X emerges. With experts warning that this unknown threat may surpass past outbreaks like COVID-19, the question is: How prepared is Africa to handle such a crisis? As international bodies focus on pandemic preparedness, Africa’s readiness will play a crucial role in mitigating the impact of this hypothetical but looming threat. 🔗 Explore more in the blog [https://lnkd.in/ebPij62W] #DiseaseX #AfricaPandemic #GlobalHealth #PandemicPrevention

🚨 Did you know? Every year, 2.6 million children in Africa die before their fifth birthday from preventable illnesses like pneumonia, diarrhoea, and malaria. Despite these staggering numbers, over 50% of paediatric treatments lack controlled trial data. This gap leaves millions of children vulnerable to receiving inadequate or ineffective medications. 🌍 Paediatric clinical trials are not just important—they're lifesaving. Yet, children remain under-represented in research, especially in Africa, where the need is greatest. Want to know why this is happening and what we can do about it?  Dive into our latest blog post to explore the urgent need for paediatric clinical trials in Africa and how they can transform lives. Read the full article here: [https://lnkd.in/dysgkz9a] #Paediatrics #ClinicalTrials #HealthcareInAfrica #Utanocro

According to the World Health Organization, cancer is a major public health concern in Africa, causing over 700,000 deaths annually, with predictions of over one million deaths by 2030. Factors like population growth, longer life expectancy, obesity, and smoking contribute greatly to this rise. Low and middle-income countries face the heaviest burden, accounting for 70% of the global cancer deaths. Despite this, cancer remains a low priority compared to other diseases like malaria and HIV/AIDS. With 1.1 million new cancer cases occurring annually, innovative strategies for prevention, early diagnosis, and affordable treatments are crucial. Expanding clinical trials is key! South Africa and Egypt currently lead in hosting trials, but distribution remains poor across the continent. Nonetheless, expanding research capacity relies on both national and international collaborative cancer research efforts. For more information on ongoing cancer trials and strategies to change the status quo, read our full article [https://lnkd.in/eJ2FPA37]. #CancerResearch #GlobalHealth #ClinicalTrials #CancerAwareness #SignificantCancer

As the rest of the world advances in healthcare, Africa despite being the second most populous continent with over 1.2 billion people accounts for only 5% of global clinical trial enrollment, according to the African Clinical Research Association (ACRA). The continent's diverse population offer a rich genetic pool for clinical trials, raising the question of why more sponsors are not taking advantage of this opportunity. It is crucial to test medical interventions across diverse populations, as different groups may respond differently due to variations in disease prevalence, genetic makeup, and other determinants. Yet, most genomic data used in research is derived from Europe, the United Kingdom, and North America. Despite Africa's significant role in human evolution and its vast, genetically diverse population, it remains underrepresented in genetic studies. This lack of representation not only limits healthcare advancements in Africa but also restricts global medical research. The pharmaceutical industry's leaders are increasingly acknowledging the importance of diversity and inclusion, with some committing to expand their presence in Africa. This underscores the urgent need for African governments to enhance their efforts, focusing on refining regulatory policies and raising awareness about the opportunities and challenges associated with clinical trials. Discover More Details: https://lnkd.in/e3W_txGC #AfricaRising #GlobalHealth #ClinicalResearchAfrica

Explore our latest blog article comparing Decentralized and Traditional Clinical Trials. We delve into their benefits, challenges, and advancements shaping the landscape of both models. Join the discussion on which approach is best suited for future studies. Check out the full article here: https://lnkd.in/e67ikFYy #ClinicalResearch #DecentralizedTrials #HealthcareInnovation #PatientCare

Despite having 18% of the world's population, Africa still contributes to just ≤5% of the data generated from clinical trials. This remains insignificant in contributing to the improvement of healthcare for Africans, especially in this new era of personalized medicine. As with everything in life, you can either let a challenge pull you down or rise and overcome it, and that is exactly what we at Utano CRO are doing. According to the World Health Organization (WHO) scale, five African nations are currently rated at maturity level three for regulating vaccines and medicine trials. Utano is proud to say that we are actively present in all five countries i.e. South Africa, Nigeria, Egypt, Tanzania, and Ghana. With an actively growing presence now spanning 25 African nations, we can confidently say that Africa's contribution to the field of clinical research is set to increase markedly. As we celebrate International Clinical Trial Day, we would like to remind you to join us in ensuring that our beautiful continent has her fair share as an equal at the table. To learn more about us, visit https://utanocro.com/. Also, go through this article; https://lnkd.in/eswRPTJn by the African Clinical Research Association (ACRA) to see more data on the statistics of clinical research in Africa. Happy International Clinical Trials Day!!! AFRILEADTECH RESEARCH #utanocro #clinicalresearch #clinicaltrials #healthcare #africa #nigeria #ghana #clinicaltrialsday

April 25th is World Malaria Day. Malaria presents a significant burden on global public health, particularly in regions with high transmission rates such as sub-Saharan Africa, Southeast Asia, and South America. It disproportionately affects vulnerable populations, hindering economic development, straining healthcare systems, and causing substantial morbidity and mortality. Despite being preventable and treatable, addressing malaria effectively requires concerted efforts to implement and sustain comprehensive control and elimination strategies. This recent article: https://lnkd.in/eAFZ-Bph by Gavi, the Vaccine Alliance summarises the five innovations that could help to eliminate malaria. We at Utano CRO are dedicated to supporting the battle against malaria in Africa. #utanocro #clinicalresearch #clinicaltrials #malaria #worldmalariaday #healthcare #africa #nigeria #ghana

The Clinical Research Master Class 03 May 2024 Join us on April 22, 2024, at 17:30 to answer your questions. If you still need to be added to our database, please visit our website to create your account. You can also reach out to us at [email protected]. Join our mailing list: https://lnkd.in/dzrg9uVG Denise Witbooi Akanksha Jainxikombiso malulekaUtano CROChukwunonso UdehStephen Larbi Darkoh JnrChantal Sewsaran Nyeleti Bicky Mthombeni

Participants at HJF Medical Research International in Abuja, Nigeria, have been vaccinated in the first Phase 2 clinical trial of a Lassa fever virus (LASV) vaccine candidate to date, according to IAVI, a nonprofit scientific research organization, and the trial sponsor. The study (IAVI C105/PREVAIL15) - https://lnkd.in/ei9WgtFu is funded by CEPI (Coalition for Epidemic Preparedness Innovations), an innovative global partnership working to accelerate the development of vaccines against epidemic and pandemic threats. Lassa fever poses a significant public health challenge in Nigeria, with periodic outbreaks, particularly during the dry season. Challenges include underreporting and misdiagnosis due to limited surveillance and diagnostic capabilities, compounded by inadequate healthcare infrastructure, especially in rural areas. Addressing these issues requires improved surveillance, diagnostic tools, healthcare access, and community education on preventive measures like rodent control and hygiene practices. The ongoing clinical trial is poised to significantly enhance the collective effort in combating the disease. https://lnkd.in/e7NzVQ6F